Shagun Singh
Stock Analyst at RBC Capital
(2.25)
# 2,263
Out of 4,877 analysts
207
Total ratings
46.89%
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Shagun Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JNJ Johnson & Johnson | Reiterates: Outperform | $181 | $152.75 | +18.49% | 21 | Jun 5, 2025 | |
| MDT Medtronic | Maintains: Outperform | $105 → $101 | $87.17 | +15.87% | 21 | May 22, 2025 | |
| OM Outset Medical | Maintains: Sector Perform | $14 → $21 | $19.21 | +9.32% | 11 | May 21, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $125 → $112 | $91.21 | +22.79% | 14 | May 6, 2025 | |
| TFX Teleflex | Maintains: Sector Perform | $150 → $145 | $118.36 | +22.51% | 20 | May 2, 2025 | |
| ZYXI Zynex | Maintains: Sector Perform | $5 → $4 | $2.58 | +55.04% | 7 | Apr 30, 2025 | |
| PEN Penumbra | Maintains: Outperform | $315 → $330 | $256.63 | +28.59% | 14 | Apr 24, 2025 | |
| BSX Boston Scientific | Maintains: Outperform | $116 → $120 | $107.41 | +11.72% | 15 | Apr 24, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $630 → $605 | $543.41 | +11.33% | 14 | Apr 23, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $140 → $145 | $136.01 | +6.61% | 13 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $215 | $129.77 | +65.68% | 5 | Apr 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $340 | $314.18 | +8.22% | 1 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $65 → $55 | $18.64 | +195.06% | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $78.21 | +8.68% | 21 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $425 → $435 | $395.63 | +9.95% | 19 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $92 | $59.02 | +55.88% | 5 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $115 | $87.29 | +31.74% | 4 | Oct 25, 2024 |
Johnson & Johnson
Jun 5, 2025
Reiterates: Outperform
Price Target: $181
Current: $152.75
Upside: +18.49%
Medtronic
May 22, 2025
Maintains: Outperform
Price Target: $105 → $101
Current: $87.17
Upside: +15.87%
Outset Medical
May 21, 2025
Maintains: Sector Perform
Price Target: $14 → $21
Current: $19.21
Upside: +9.32%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Outperform
Price Target: $125 → $112
Current: $91.21
Upside: +22.79%
Teleflex
May 2, 2025
Maintains: Sector Perform
Price Target: $150 → $145
Current: $118.36
Upside: +22.51%
Zynex
Apr 30, 2025
Maintains: Sector Perform
Price Target: $5 → $4
Current: $2.58
Upside: +55.04%
Penumbra
Apr 24, 2025
Maintains: Outperform
Price Target: $315 → $330
Current: $256.63
Upside: +28.59%
Boston Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $116 → $120
Current: $107.41
Upside: +11.72%
Intuitive Surgical
Apr 23, 2025
Maintains: Outperform
Price Target: $630 → $605
Current: $543.41
Upside: +11.33%
Abbott Laboratories
Apr 17, 2025
Maintains: Outperform
Price Target: $140 → $145
Current: $136.01
Upside: +6.61%
Apr 15, 2025
Maintains: Outperform
Price Target: $260 → $215
Current: $129.77
Upside: +65.68%
Mar 6, 2025
Initiates: Outperform
Price Target: $340
Current: $314.18
Upside: +8.22%
Feb 27, 2025
Maintains: Outperform
Price Target: $65 → $55
Current: $18.64
Upside: +195.06%
Feb 12, 2025
Reiterates: Outperform
Price Target: $85
Current: $78.21
Upside: +8.68%
Jan 29, 2025
Maintains: Outperform
Price Target: $425 → $435
Current: $395.63
Upside: +9.95%
Nov 6, 2024
Maintains: Outperform
Price Target: $80 → $92
Current: $59.02
Upside: +55.88%
Oct 25, 2024
Maintains: Outperform
Price Target: $120 → $115
Current: $87.29
Upside: +31.74%